# Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis

> **NCT02643823** · PHASE1 · UNKNOWN · sponsor: **Shenzhen Hornetcorn Bio-technology Company, LTD** · enrollment: 40 (estimated)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **BIOLOGICAL:** hUC-MSC + DMARDs
- **DRUG:** DMARDs

## Key facts

- **NCT ID:** NCT02643823
- **Lead sponsor:** Shenzhen Hornetcorn Bio-technology Company, LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2017-01
- **Final completion:** 2017-06
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2016-05-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02643823

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02643823, "Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02643823. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*